GlassScriptPhysician profile
Jeffrey S Devaney
NPI 1376716399
$1,001.91
in general payments reported to CMS, 2019-2025
12 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.32 · 2022: $123 · 2023: $262 · 2024: $310 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $279.48 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Medtronic, INC. | $272.18 | 2021-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Painteq LLC | $92.16 | 2022-2023 | Painteq |
| Vertex Pharmaceuticals Incorporated | $68.25 | 2025 | |
| Phathom Pharmaceuticals, INC. | $67.97 | 2024 | Voquezna |
| Amgen INC. | $50.59 | 2021-2022 | |
| Spineart USA INC | $45.55 | 2024 | |
| Abbott Laboratories | $41.90 | 2023-2025 | Eterna, Proclaim |
| Hologic Sales and Service, LLC | $26.00 | 2024 | I -View Contrast Enhanced Digital Mammography, Brevera Breast Biopsy System, 3dquorum |
| Merck Sharp & Dohme LLC | $22.36 | 2022 | |
| Abbvie INC. | $18.34 | 2023 | |
| Spr Therapeutics, INC | $17.13 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Devaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.